Victrix Investment Advisors Invests $303,000 in Cardinal Health, Inc. (NYSE:CAH)

Victrix Investment Advisors purchased a new stake in Cardinal Health, Inc. (NYSE:CAH) in the 4th quarter, according to the company in its most recent 13F filing with the SEC. The fund purchased 2,559 shares of the company’s stock, valued at approximately $303,000.

A number of other large investors also recently bought and sold shares of the business. Rothschild Investment LLC increased its position in shares of Cardinal Health by 10.1% in the fourth quarter. Rothschild Investment LLC now owns 858 shares of the company’s stock valued at $101,000 after buying an additional 79 shares in the last quarter. Private Trust Co. NA increased its holdings in Cardinal Health by 11.0% in the 4th quarter. Private Trust Co. NA now owns 930 shares of the company’s stock worth $110,000 after acquiring an additional 92 shares in the last quarter. Checchi Capital Advisers LLC raised its position in Cardinal Health by 2.7% during the fourth quarter. Checchi Capital Advisers LLC now owns 3,479 shares of the company’s stock worth $411,000 after acquiring an additional 93 shares during the period. TIAA Trust National Association raised its position in Cardinal Health by 4.5% during the fourth quarter. TIAA Trust National Association now owns 2,183 shares of the company’s stock worth $258,000 after acquiring an additional 94 shares during the period. Finally, MWA Asset Management lifted its holdings in Cardinal Health by 2.9% during the fourth quarter. MWA Asset Management now owns 3,324 shares of the company’s stock valued at $393,000 after purchasing an additional 95 shares in the last quarter. Institutional investors and hedge funds own 87.17% of the company’s stock.

Cardinal Health Stock Up 1.5%

CAH stock opened at $154.23 on Monday. Cardinal Health, Inc. has a 52-week low of $93.17 and a 52-week high of $154.68. The stock has a market cap of $36.81 billion, a price-to-earnings ratio of 28.77, a price-to-earnings-growth ratio of 1.49 and a beta of 0.66. The business has a fifty day moving average of $137.09 and a two-hundred day moving average of $127.92.

Cardinal Health (NYSE:CAH) last released its quarterly earnings results on Thursday, May 1st. The company reported $2.35 earnings per share for the quarter, topping analysts’ consensus estimates of $2.15 by $0.20. The business had revenue of $54.88 billion during the quarter, compared to analysts’ expectations of $55.33 billion. Cardinal Health had a negative return on equity of 59.57% and a net margin of 0.59%. The company’s revenue was up .0% compared to the same quarter last year. During the same period in the prior year, the business posted $2.08 EPS. As a group, sell-side analysts anticipate that Cardinal Health, Inc. will post 7.95 EPS for the current year.

Cardinal Health Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, July 15th. Stockholders of record on Tuesday, July 1st will be issued a $0.5107 dividend. This is a positive change from Cardinal Health’s previous quarterly dividend of $0.51. This represents a $2.04 annualized dividend and a dividend yield of 1.32%. The ex-dividend date of this dividend is Tuesday, July 1st. Cardinal Health’s dividend payout ratio is currently 31.83%.

Wall Street Analysts Forecast Growth

Several research analysts recently weighed in on CAH shares. Citigroup restated a “neutral” rating on shares of Cardinal Health in a research report on Thursday, May 1st. JPMorgan Chase & Co. increased their target price on Cardinal Health from $142.00 to $145.00 and gave the company a “neutral” rating in a report on Tuesday, February 4th. StockNews.com raised Cardinal Health from a “buy” rating to a “strong-buy” rating in a research note on Monday, May 5th. Robert W. Baird boosted their price target on Cardinal Health from $156.00 to $170.00 and gave the stock an “outperform” rating in a research report on Friday, May 2nd. Finally, Wells Fargo & Company raised their price objective on Cardinal Health from $135.00 to $136.00 and gave the company an “equal weight” rating in a report on Tuesday, February 4th. Four equities research analysts have rated the stock with a hold rating, ten have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $146.43.

Cardinal Health Profile

Cardinal Health, Inc operates as a healthcare services and products company in the United States, Canada, Europe, Asia, and internationally. It provides customized solutions for hospitals, healthcare systems, pharmacies, ambulatory surgery centers, clinical laboratories, physician offices, and patients in the home.